USPTO serial 90323594
BUOY
Reviewed by CopyMark Law Group
Status 807Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- MONINGHOFF, KIM TERESA
- Law office
- TMO LAW OFFICE 113
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with BUOY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
New York, NY, US
New York, NY, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
DARREN M. GELIEBTER
DARREN M. GELIEBTER LOMBARD & GELIEBTER LLP1325 Avenue of the Americas, 28th FloorNEW YORK, NY 10019United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Electronic data collection, data processing, and data analysis, all of the foregoing for business purposes, namely, for use in connection with the collection, screening, testing, transport, distribution, and storage of human blood plasma; none of the foregoing for use in connection with Internet-based health care, telehealth, health assessment, disease diagnosis, treatment and management, medical record analysis, or health care referral services provided to patients, healthcare providers, or healthcare researchers | ACTIVE | Dec 7, 2020 |
| 042 | Software as a service (SAAS) services featuring software for operating, administering and managing blood plasma collection and donation centers, and the associated compensation and incentive reward programs administered therewith; Software development for use in connection with operating, administering and managing of blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Mobile application software development for use in connection with operating, administering and managing blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Application service provider featuring application programming interface (API) software and on-line, non-downloadable software development tools for use in operating, administering and managing of blood plasma donation and collection centers and the associated compensation and incentive reward programs administered therewith; platform as a service (PAAS) featuring application programming interface (API) software and on-line, non-downloadable software development tools for operating, administering and managing blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Consultancy relating to computer software for the operation, administration, and management of blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; Software subscription, namely, rental of computer software for use in connection with operating, administering and managing blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; leasing and customizing white label software platform for use by blood plasma donation and collection centers; none of the foregoing for use in connection with Internet-based health care, telehealth, health assessment, disease diagnosis, treatment and management, medical record analysis, or health care referral services provided to patients, healthcare providers, or healthcare researchers | ACTIVE | Dec 7, 2020 |
| 045 | Licensing of software for the operation, administration, and management of blood plasma donation and collection centers, and the associated compensation and incentive reward programs administered therewith; white label software services, namely, licensing of computer software platform to blood plasma donation and collection centers for use in association with their own branding; none of the foregoing for use in connection with Internet-based health care, telehealth, health assessment, disease diagnosis, treatment and management, medical record analysis, or health care referral services provided to patients, healthcare providers, or healthcare researchers | ACTIVE | Dec 7, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Source Donor Inc.
- Other trademarks owned by Source Donor Inc.
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named BUOY
- Prosecution event GNRN explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 23, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 23, 2026 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 10, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 8, 2026 | IUAF | USE AMENDMENT FILED | — |
| Sep 8, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 17, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 16, 2026 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jul 16, 2026 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 5, 2026 | EXT5 | SOU EXTENSION 5 FILED | — |
| Mar 5, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 5, 2025 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 5, 2025 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 5, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 15, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 3, 2025 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 3, 2025 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 3, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 27, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 27, 2024 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 27, 2024 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 27, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 1, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Feb 29, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 29, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Feb 29, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 5, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 26, 2023 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jul 26, 2023 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jul 26, 2023 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| Jun 3, 2022 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Dec 16, 2021 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 2, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 1, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 1, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 30, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 30, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 30, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 22, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 16, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 20, 2020 | NWAP | NEW APPLICATION ENTERED | — |